CHARLES B HAASER Insider Trading
Get free email notifications about insider trading for CHARLES B HAASER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CHARLES B HAASER. CHARLES B HAASER is a Principal Accounting Officer in ABIOMED INC ($ABMD) and a Principal Financial Officer in ABIOMED INC ($ABMD) and a Chief Accounting Officer in METABOLIX, INC. ($MBLX) and a VP Fin & Chief Accting Officer in METABOLIX, INC. ($MBLX).
Address: C/O ABIOMED, INC. 22 CHERRY HILL DRIVE DANVERS 01923 MA
Companies in which CHARLES B HAASER is an Insider
ABIOMED INC
Trading Symbol: ABMDIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of CHARLES B HAASER: Principal Accounting Officer, Principal Financial Officer
Holdings: 2,379 shares
Current Value: $261,547
Latest Transaction: Jun 02 2006
$ABMD Market Capitalization: $4.72B
$ABMD Previous Close: $109.94
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
YIELD10 BIOSCIENCE, INC.
Trading Symbol: MBLXIndustry: MISCELLANEOUS PLASTIC PRODUCTS [3080]
Position of CHARLES B HAASER: VP Fin & Chief Accting Officer, Chief Accounting Officer
Holdings: 4,725 shares
Latest Transaction: Mar 03 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of CHARLES B HAASER
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 03 2021 | MBLX | YIELD10 BIOSCIENCE ... | HAASER CHARLES B | VP Fin & Chief Acct ... | Grant | A | 16.03 | 1,950 | 31,259 | 4,725 | 2.8 K to 4.7 K (+70.27 %) |
Feb 16 2021 | MBLX | YIELD10 BIOSCIENCE ... | HAASER CHARLES B | VP Fin & Chief Acct ... | Payment of Exercise | F | 22.77 | 693 | 15,780 | 2,775 | 3.5 K to 2.8 K (-19.98 %) |
Feb 16 2021 | MBLX | YIELD10 BIOSCIENCE ... | HAASER CHARLES B | VP Fin & Chief Acct ... | Payment of Exercise | F | 22.77 | 693 | 15,780 | 2,775 | 3.5 K to 2.8 K (-19.98 %) |
Jan 27 2021 | MBLX | YIELD10 BIOSCIENCE ... | HAASER CHARLES B | VP Fin & Chief Acct ... | Option Exercise | A | 16.49 | 11,500 | 189,635 | 11,500 | |
Aug 13 2020 | MBLX | YIELD10 BIOSCIENCE ... | HAASER CHARLES B | VP Fin & Chief Acct ... | Payment of Exercise | F | 6.55 | 587 | 3,845 | 3,468 | 4.1 K to 3.5 K (-14.48 %) |
May 29 2020 | MBLX | YIELD10 BIOSCIENCE ... | HAASER CHARLES B | VP Fin & Chief Acct ... | Option Exercise | A | 5.86 | 21,000 | 123,060 | 21,000 | |
May 23 2019 | MBLX | YIELD10 BIOSCIENCE ... | HAASER CHARLES B | VP Fin & Chief Acct ... | Option Exercise | A | 0.90 | 60,000 | 54,000 | 60,000 |